Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFIRFI Meaning: What Is an RFI?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Q301--Research Lab Services - Blood Assays for Alzheimer's

U.S. Department Of Veterans Affairs·Pennsylvania

Q301--Research Lab Services - Blood Assays for Alzheimer's

Closes 5/11/2026$5k – $15kRequest for Information
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

This is a sources sought notice for blood assay services for the Minneapolis VA Medical Center. The Department of Veterans Affairs is seeking information from potential vendors to determine their ability to provide these services. The services include APOE and pTau217 blood tests to assess Alzheimer's risk. The contractor will be required to process blood samples, deliver sample test results, and invoice the government. The contract will be a firm-fixed price, indefinite delivery/indefinite quantity (IDIQ) contract with a 3-year period of performance. * The contractor must have published evidence of their ability to perform sensitive, repeatable, and validated APOE and pTau217 blood tests. * The contractor must have expertise in providing accurate and sensitive APOE and pTau217 assays. * The contractor must have CLIA or other relevant lab certifications. * The contractor must be able to process blood samples using pre-frozen 1.5mL EDTA plasma/ 1.5mL red blood cells/ associated buffy coat. * The contractor must be able to provide results in ng/mL and share results with the study team within 15 days of receipt.

Attached files

Contact

Renee Kale(Contracting Officer)

[email protected]

(412) 822-3757

Key dates

Opened
4/29/2026
Closes
5/11/2026
Duration
3 years

Last updated

Details

Type
Request for Information
Industry
Healthcare and Medical Services
NAICS
541380
Solicitation №
36C24E26Q0038

Budget estimate

$5,000 – $15,000

The budget for this contract can be estimated based on the number of samples to be processed and the cost of each test. Assuming an average cost of $100 per test, the total budget for the 3-year period can be estimated as follows: * 25 samples per year x 3 years = 75 samples * 75 samples x $100 per test = $7,500 However, this is a rough estimate and the actual budget may vary depending on the contractor's pricing and the actual number of samples processed.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 73%

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. Department Of Veterans Affairs·Illinois

72% match

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Closes 11/3/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

72% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

72% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 6/17/2027Opened 8/13/2026

U.S. Department Of Veterans Affairs·New Jersey

72% match

Q301--Reference and Esoteric Laboratory Testing

Closes 11/30/2026Opened 10/30/2026

U.S. Department Of Veterans Affairs·Texas

71% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. Department Of Defense·Maryland

71% match

RFI Alzheimer’s Research Program (AZRP) Public

Closes 12/4/2026Opened 10/27/2026

Iowa State University·Iowa

70% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. Department Of Health And Human Services·Maryland

70% match

NIA:Non-Competitive Combined Synopsis/Solicitation

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

70% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

70% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

70% match

Specialized Alcohol Research Centers (P50 Clinical trial Optional)

Closes 1/27/2027Opened 1/30/2026

U.S. National Institutes of Health·United States of America

70% match

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)

Closes 5/26/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

69% match

Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)

Closes 1/9/2029Opened 6/9/2025

U.S. National Institutes of Health·United States of America

69% match

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Closes 11/9/2026Opened 2/12/2026

U.S. National Institutes of Health·United States of America

69% match

The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)

Closes 10/31/2026Opened 5/18/2026

U.S. National Institutes of Health·United States of America

69% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. Department Of Defense·Virginia

69% match

Laboratory Support Services

Closes 11/9/2026Opened 10/23/2026

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

69% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

69% match

Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

Closes 9/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

68% match

NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)

Closes 3/1/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

68% match

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Closes 1/7/2028Opened 10/28/2024

U.S. National Institutes of Health·United States of America

68% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

LA County Sheriff·California

68% match

RFSQ - DNA Laboratory Services

Rolling / TBD closeOpened 11/9/2021

U.S. National Institutes of Health·United States of America

68% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024